Jump to content

User:Wadewitz/Epilepsy collaboration page: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
two sources
Line 56: Line 56:
*Choudhery V, Townend W. [http://emj.bmj.com/cgi/content/full/23/6/472 Best evidence topic reports. Lorazepam or diazepam in paediatric status epilepticus]. Emerg Med J. 2006 Jun;23(6):472-3. PMID 16714516.
*Choudhery V, Townend W. [http://emj.bmj.com/cgi/content/full/23/6/472 Best evidence topic reports. Lorazepam or diazepam in paediatric status epilepticus]. Emerg Med J. 2006 Jun;23(6):472-3. PMID 16714516.
*Wilby J, Kainth A, Hawkins N, ''et al'. [http://www.hta.ac.uk/fullmono/mon915.pdf Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation] (PDF). Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. PMID 15842952.
*Wilby J, Kainth A, Hawkins N, ''et al'. [http://www.hta.ac.uk/fullmono/mon915.pdf Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation] (PDF). Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. PMID 15842952.
*Marson AG, Al-Kharusi AM, Alwaidh M, ''et al''. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet. 2007 Mar 24;369(9566):1000-15. PMID 17382827.
*Marson AG, Al-Kharusi AM, Alwaidh M, ''et al''. [http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17382827 The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial]. Lancet. 2007 Mar 24;369(9566):1000-15. PMID 17382827.
*Marson AG, Al-Kharusi AM, Alwaidh M, ''et al''. [http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17382828 The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial]. Lancet. 2007 Mar 24;369(9566):1016-26. PMID 17382828.
*Marson AG, Al-Kharusi AM, Alwaidh M, ''et al''. [http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17382828 The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial]. Lancet. 2007 Mar 24;369(9566):1016-26. PMID 17382828.
*Marson AG, Appleton R, Baker GA, ''et al''. [http://www.hta.ac.uk/fullmono/mon1137.pdf A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial] (PDF). Health Technol Assess. 2007 Oct;11(37):1-154. PMID 17903391.
*Marson AG, Appleton R, Baker GA, ''et al''. [http://www.hta.ac.uk/fullmono/mon1137.pdf A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial] (PDF). Health Technol Assess. 2007 Oct;11(37):1-154. PMID 17903391.

Revision as of 18:57, 23 November 2007

Article structure

Classification

Seizure types

Generalized seizures
  • Tonic-clonic seizures
  • Absence seizures
  • Myoclonic seizures
  • Atonic seizures
Focal seizures
  • Focal sensory
  • Focal motor
  • Gelastic seizures
  • Hemiclonic seizures
Status epilepticus

Seizure disorders

Characteristics

Causes

Triggers

  • Flickering light[1]
  • Thinking music[2]
  • Eating[3]
  • Praxis [Exercise?][4]
  • Somatosensory [Explain][5]
  • Proprioceptive [Explain][6]
  • Reading[7]
  • Exposure to hot water[8]
  • Being startled[9]

Pathophysiology

Diagnosis

Treatment

Chronic
Emergency
Surgery

Electrophysiology

Prognosis

Epidemiology

History

Notes

Bibliography

Bibliography

[Query: Anything that is not "evidence-based" should be excluded, should it not? Awadewit | talk 04:47, 19 November 2007 (UTC)]

Books

Journals

Epilepsy Currents is the journal of the AES. Freely available online to all readers.

Web sites

Probably the most useful resource for international facts and figures. The campaign website also contains reports from around the world, though it doesn't seem to have moved on since 2005.
Has a few interesting resources. The History and the Social Consequences factsheets look promising but basic.
Has a large number of articles, literature reviews and other information pages for the professional. Some are reprints of work published in journals; others seem to be written for NSE.
The authority on classification and terminology. Useful glossary and extensive information on seizure types and syndromes.
Loads of clinical overviews of various topics. Not as highly regarded as established peer-reviewed print journals.

Clinical guildelines

Comprises a number of PDF documents that contain a wealth of UK-focused data and guidelines built on evidence-based-medicine.
These Scottish guidelines, like the NICE equivalent for England & Wales, are thoroughly reviewed and evidence-based.
A substantial number of guidelines with an American flavour. Often jointly supported by the American Epilepsy Society.